Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii - II. Prolongation of hamster-to-rat cardiac xenograft survival by combination therapy with the PG27 extract and cyclosporine

Citation
J. Wang et al., Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii - II. Prolongation of hamster-to-rat cardiac xenograft survival by combination therapy with the PG27 extract and cyclosporine, TRANSPLANT, 70(3), 2000, pp. 456-464
Citations number
40
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION
ISSN journal
00411337 → ACNP
Volume
70
Issue
3
Year of publication
2000
Pages
456 - 464
Database
ISI
SICI code
0041-1337(20000815)70:3<456:IAOTCM>2.0.ZU;2-4
Abstract
Background. PG27 is an immunosuppressive fraction purified from an extract of a Chinese medicinal plant Tripterygium wilfordii, which we investigated alone and in combination with cyclosporine (CsA) in a concordant, hamster-t o-rat cardiac xenotransplantation model. Methods. Golden Syrian hamster hearts were heterotopically transplanted int o the abdomen of Lewis rat recipients, which were treated intraperitoneally or orally with PG27, CsA, or both. Results. Combination therapy with 30 mg/kg/day of PG27 and CsA at 10 mg/kg/ day successfully suppressed acute hamster-to-rat cardiac xenograft rejectio n. Treatment with PG27 or CsA alone was ineffective, Among several effectiv e combinations, the best regimen involved PG27 at 30 mg/kg/day and CsA at 5 mg/kg/day from days 8 to 35 and then CsA at 5 mg/kg/day from days 36 to 10 0, which produced 100% survival beyond 100 days, CsA suppressed the heteros pecific lymphocytotoxic antibody response and inhibited IgG but not IgM xen oantibody production (which led to xenograft rejection), whereas PG27 alone did not prevent antibody production. The PG27/CsA combination blocked the lymphocytotoxic antibody response and IgG and IgM xenoantibody production i nduced by cardiac xenotransplantation, Conclusions, PG27 combined with CsA substantially prolonged hamster-to-rat cardiac xenograft survival, as well as completely inhibiting xenoantibody p roduction.